Cutter & Co Brokerage’s TG Therapeutics TGTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-6,525
| Closed | -$253K | – | 320 |
|
2021
Q2 | $253K | Buy |
6,525
+500
| +8% | +$19.4K | 0.06% | 237 |
|
2021
Q1 | $290K | Sell |
6,025
-180
| -3% | -$8.66K | 0.07% | 217 |
|
2020
Q4 | $323K | Buy |
+6,205
| New | +$323K | 0.08% | 185 |
|
2020
Q2 | – | Sell |
-17,550
| Closed | -$173K | – | 271 |
|
2020
Q1 | $173K | Sell |
17,550
-1,425
| -8% | -$14K | 0.07% | 191 |
|
2019
Q4 | $211K | Sell |
18,975
-965
| -5% | -$10.7K | 0.07% | 219 |
|
2019
Q3 | $112K | Sell |
19,940
-350
| -2% | -$1.97K | 0.04% | 279 |
|
2019
Q2 | $176K | Buy |
20,290
+3,650
| +22% | +$31.7K | 0.06% | 271 |
|
2019
Q1 | $134K | Sell |
16,640
-250
| -1% | -$2.01K | 0.04% | 275 |
|
2018
Q4 | $69K | Sell |
16,890
-19,100
| -53% | -$78K | 0.03% | 256 |
|
2018
Q3 | $202K | Sell |
35,990
-450
| -1% | -$2.53K | 0.07% | 254 |
|
2018
Q2 | $479K | Buy |
36,440
+2,215
| +6% | +$29.1K | 0.18% | 124 |
|
2018
Q1 | $486K | Buy |
+34,225
| New | +$486K | 0.19% | 122 |
|